Koyfin Home > Directory > Health Care > Adma Biologics > Net Income

Adma Biologics Net Income Chart (ADMA)

Adma Biologics annual/quarterly Net Income from 2010 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Adma Biologics Net Income for the quarter ending June 06, 2020 was $-20m a 43.31% decrease of -9m year over year
  • Adma Biologics Net Income for the last 12 months ending June 06, 2020 was $-61m a 9.23% decrease of -6m year over year
  • Adma Biologics Annual Net Income for 2019 was $-48m a -36.17% increase of 17m from 2018
  • Adma Biologics Annual Net Income for 2018 was $-66m a 33.44% decrease of -22m from 2017
  • Adma Biologics Annual Net Income for 2017 was $-44m a 55.40% decrease of -24m from 2016
Other Income Statement Metrics:
  • Adma Biologics EBITDA for the quarter ending December 12, 2018 was $-16m a -0.51% increase of 0m year over year
  • Adma Biologics Total Revenue for the quarter ending September 09, 2018 was $4m a -183.74% decrease of -8m year over year
View Chart On Koyfin

Quarterly ADMA Net Income Data

06/2020$-20m
03/2020$-19m
12/2019$-11m
09/2019$-11m
06/2019$-13m
03/2019$-13m
12/2018$-18m
09/2018$-15m
06/2018$-15m
03/2018$-18m

Annual ADMA Net Income Data

2019$-48m
2018$-66m
2017$-44m
2016$-20m
2015$-18m
2014$-17m
2013$-16m
2012$-7m
2011$-6m
2010$-6m